Targeting Notch4 in Cancer: Molecular Mechanisms and Therapeutic Perspectives
Mengxi Xiu,1,2 Xiaohong Zeng,3 Renfeng Shan,1 Wu Wen,1 Jianfeng Li,1 Renhua Wan1 1Department of General Surgery, The First Affiliated Hospital of Nanchang University, Nanchang University, Nanchang, People’s Republic of China; 2Second Clinical Medical College, Nanchang University, Nanchang, People’s...
Main Authors: | Xiu M, Zeng X, Shan R, Wen W, Li J, Wan R |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2021-09-01
|
Series: | Cancer Management and Research |
Subjects: | |
Online Access: | https://www.dovepress.com/targeting-notch4-in-cancer-molecular-mechanisms-and-therapeutic-perspe-peer-reviewed-fulltext-article-CMAR |
Similar Items
-
NOTCH3 limits the epithelial–mesenchymal transition and predicts a favorable clinical outcome in esophageal cancer
by: Norihiro Matsuura, et al.
Published: (2021-06-01) -
Down-regulation of E-cadherin enhances prostate cancer chemoresistance via Notch signaling
by: Wenchu Wang, et al.
Published: (2017-03-01) -
LGR5 promotes epithelial ovarian cancer proliferation, metastasis, and epithelial–mesenchymal transition through the Notch1 signaling pathway
by: Wenxue Liu, et al.
Published: (2018-07-01) -
Bevacizumab modulates retinal pigment epithelial-to-mesenchymal transition via regulating Notch signaling
by: Jing-Jing Zhang, et al.
Published: (2015-04-01) -
Targeting Pancreatic Cancer Cell Plasticity: The Latest in Therapeutics
by: Jacob M. Smigiel, et al.
Published: (2018-01-01)